Small procoagulant platelets in diabetes type 2.

Area of Science:

• Hematology
• Thrombosis Research
• Diabetes Complications

Background:

• Platelets play a crucial role in hemostasis and thrombosis.
• In vitro studies show strong agonist provocation generates small, procoagulant platelets.
• These platelets display reduced fibrinogen receptor (αIIbβ3) activation, increased Annexin V and LAMP-1 surface exposure, and compromised mitochondrial integrity.

Purpose of the Study:

• To investigate the presence and characteristics of procoagulant platelets in vivo.
• To identify specific platelet populations in type 2 diabetes mellitus (T2DM) that may contribute to thrombotic events.

Main Methods:

• Separation of whole blood platelets from T2DM subjects (n=12) into 17 density subpopulations using a linear Percoll™ gradient.
• Analysis of platelet subpopulations using multi-colour flow cytometry.
• Assessment of surface markers including PAC-1 (αIIbβ3 activation), Annexin V (phosphatidylserine exposure), LAMP-1 (lysosomal release), and mitochondrial transmembrane potential.

Main Results:

• Small platelets were concentrated in medium-dense fractions (1.065-1.053 kg/L).
• These small platelets showed significantly lower PAC-1 activity (p<0.001) compared to other subpopulations.
• Enhanced surface Annexin V and LAMP-1, along with reduced mitochondrial transmembrane potential, were observed in these small platelets.

Conclusions:

• Small circulating platelets in type 2 diabetes exhibit procoagulant characteristics.
• These findings suggest that specific platelet subpopulations may contribute to the increased thrombotic risk associated with T2DM.